Discover

GLMD
Galmed Pharmaceuticals Ltd.
0.56
6 x 0.59
1 x 0.63
bid
ask
-
0.04
6.10%
4 @ 04:00 PM
0.59 +0.03 (5.26%)
Ytd-25.85%
1y-61.59%
0.55
day range
0.57
0.41
52 week range
1.65
Open0.57Prev Close0.59Low0.55High0.57Mkt Cap4.60M
Vol29.52KAvg Vol771.04KEPS-2.17P/E-0.26Forward P/E-2.94
Beta0.80Short Ratio0.27Inst. Own0.48%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning09-0150-d Avg0.58200-d Avg0.741yr Est12.00
Income Statement
Operating Expenses2.04M
Research and Development Expense1.36M
Selling, General and Administrative Expense684.00K
Operating Income-2.04M
Interest Expense-134.00K
Net Income-1.91M
Net Income Common Stock-1.91M
Net Income Common Stock (USD)-1.91M
Consolidated Income-1.91M
Earnings per Basic Share-0.29
Earnings per Basic Share (USD)-0.29
Earnings per Diluted Share-0.29
Earning Before Interest & Taxes (EBIT)-2.04M
Earning Before Interest & Taxes (USD)-2.04M
Weighted Average Shares6.59M
Weighted Average Shares Diluted6.59M
Balance Sheet
Cash and Equivalents1.73M
Cash and Equivalents (USD)1.73M
Investments13.85M
Investments Current13.85M
Trade and Non-Trade Receivables451.00K
Current Assets16.03M
Total Assets16.03M
Current Liabilities2.08M
Total Liabilities2.08M
Accumulated Retained Earnings (Deficit)-212.69M
Accumulated Other Comprehensive Income-383.00K
Shareholders Equity13.95M
Shareholders Equity (USD)13.95M
Trade and Non-Trade Payables2.08M
Cash Flow
Net Cash Flow / Change in Cash & Cash Equivalents-2.38M
Net Cash Flow from Investing152.00K
Net Cash Flow - Investment Acquisitions and Disposals152.00K
Net Cash Flow from Operations-2.54M
Share Based Compensation156.00K